Krystal Biotech Inc (KRYS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2024 | 03-2024 | 12-2023 | 09-2023 | 06-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 345,786 | 359,006 | 358,328 | 373,241 | 275,875 |
| Marketable Securities | 213,826 | 179,253 | 173,850 | 188,828 | 201,642 |
| Receivables | 103,236 | 46,467 | 42,040 | 9,316 | N/A |
| Inventories | 12,179 | 11,037 | 6,985 | 5,278 | N/A |
| TOTAL | $682,772 | $602,248 | $587,909 | $582,128 | $484,004 |
| Non-Current Assets | |||||
| PPE Net | 158,808 | 160,011 | 161,202 | 164,029 | 163,737 |
| Investments And Advances | 69,292 | 83,996 | 61,954 | 36,548 | 28,410 |
| Other Non-Current Assets | 6,786 | 7,041 | 7,290 | 7,645 | 7,875 |
| TOTAL | $234,886 | $251,048 | $230,446 | $208,222 | $200,022 |
| Total Assets | $917,658 | $853,296 | $818,355 | $790,350 | $684,026 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,425 | 5,359 | 4,132 | 4,340 | 4,446 |
| Accrued Expenses | 65,065 | 40,800 | 27,488 | 21,742 | 17,923 |
| TOTAL | $71,851 | $47,589 | $33,094 | $27,583 | $23,898 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 6,914 | 6,465 | 6,620 | 6,819 | 7,014 |
| TOTAL | $6,914 | $6,465 | $6,620 | $6,819 | $7,014 |
| Total Liabilities | $78,765 | $54,054 | $39,714 | $34,402 | $30,912 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 28,730 | 28,558 | 28,293 | 28,206 | 27,994 |
| Retained earnings | -253,327 | -268,895 | -269,827 | -278,519 | -359,266 |
| Other shareholders' equity | -634 | -299 | 638 | -382 | -236 |
| TOTAL | $838,893 | $799,242 | $778,641 | $755,948 | $653,114 |
| Total Liabilities And Equity | $917,658 | $853,296 | $818,355 | $790,350 | $684,026 |